The Board Meeting on Biopharma Boardroom Diversity 2017 London
This Liftstream event, in partnership with MedCity, brings together 200 life sciences and investment executives to discuss intentional solutions for increasing boardroom and leadership diversity within the industry. The event will explore the business case of diverse leadership, including improved innovation, strategic competitive advantage, financial performance, enhanced company culture and human capital management.
Leaders implementing the UK’s prominent diversity initiatives aimed at increasing the participation of women and under-represented groups in UK business will also share their experience, insights and best-practice to enact change.
The event format builds on the very successful annual diversity conference Liftstream hosts in the United States.
Event Location: BMA, Tavistock Square, London. WC1H 9JP. - United Kingdom
Event Date: March 28th 2017
3.00pm - 3.30pm – Event Registration and Networking
3.30pm – 3.40pm – Welcoming Address
3.40pm – 4.00pm – Keynote Speaker
Margot James MP, Parliamentary Under Secretary of State, Minister for Small Business, Consumers and Corporate Responsibility - UK Government
4.00pm – 4.30pm – Panel – Surveying the UK’s Diversity Landscape: Policies and Programmes...Action to Embed Lasting Change!
4.30pm – 4.45pm – Expert Presentation to the Board
4.45pm – 5.00pm – Coffee Break
5.00pm – 6.30pm – ‘The Board Meeting’ (main panel)
Under the direction of a Chairperson, a gender balanced board of leading industry executives will debate the value of diverse leadership. The
board's agenda will tackle the most prominent questions in the three following areas:
• Investing, Venture, and Management
• Boardroom Process and Governance
6.30pm – 7.30pm – Networking Reception and Close
Speakers will include:
Dr Annalisa Jenkins - CEO of Dimension Therapeutics and non-executive director of MedCity, Ardelyx, Biothera, and Viventia Bio, Inc.; John Berriman - Chairman at Confo Therapeutics, Depixus, ReNeuron Group, Autifony Therapeutics; Dr Denise Scots-Knight - CEO and Founder at Mereo Biopharma Group, Plc., non-executive director OncoMed and Albireo; Prof. Isabel Fernandez-Mateo - Professor of Strategy and Entrepreneurship, London Business School, Jeanne Bolger - VP Venture Investments, J&J Innovation JJDC Denis Woulfe - Partner and Vice Chairman, Deloitte, Co-Chair MACA and Board Member of Women's Business Council; Gerry Brown, Chairman, Novaquest Capital Management, Pavita Cooper, Steering Committee Member of 30% Club, Chair of CMI Diversity Advisory Group and Founder of More Difference. Roel Bulthuis, SVP and Managing Director, Merck Ventures, Dr Elena Doldor, Assistant Professor in Organizational Behaviour, School of Business and Management Queen Mary University of London and Senior Research Fellow - Cranfield School of Management, Catherine Moukheibir, Chairperson of MedDay Pharma, non-executive director Ablynx, Cerenis and Zealand Pharma; Dr Yvonne Thompson CBE, Entrepreneur, Author and Steering Committee Member of the Parker Review. Dr Stephen Bunting, Chairman, Abingworth LLP., Paul George, Executive Director of Corporate Governance and Reporting, Financial Reporting Council
To register your interest to attend, please follow this link: REGISTER HERE
The delegation is restricted to 200 people, so please register promptly to avoid disappointment. (All registrations will be subject to final approval and service providers limited)
- Providing a single front door and concierge service for industry and investors looking for partners, infrastructure and expertise
- Facilitating and supporting collaboration across all parts of the sector to turn innovations into commercial products and services
- Fostering an environment that supports and encourages entrepreneurialism
- Raising awareness globally of the region’s rich life sciences ecosystem